CTNMContineum Therapeutics, Inc.
$13.21+16% 1Y
$13.21
$9.1752 weeks$17.56
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Rangebound, no clear trend. Price is −4% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CTNM is trading
Contineum Therapeutics, Inc. is +16% over the past year while the S&P 500 is +18%: 2.2 points behind the market.
+16%
1-year return · S&P 500 +18%
- vs 200-day average
- −3.8%
vs 200-day average · below trend, but not far
- RSI (14)
- 48
RSI (14) · neutral
- Below its 52-week high
- 25%
Below its 52-week high
Details›
- Last close2026-10-08
- $13.21
- 1 monthS&P 500 +1.6%
- −13%
- 1 yearS&P 500 +18%
- +16%
- vs 50-day average$14.77
- −11%
- 52-week high
- $17.56
- 52-week low
- $9.17
- Annualised volatility
- 84%
| Year | Return |
|---|---|
| 2026 (year to date) | +16% |
| 2025 | −22% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 2 | 1 of 2 | −4.2% |
| Feb | 2 | 1 of 2 | −10% |
| Mar | 2 | 0 of 2 | −7.9% |
| Apr | 2 | 0 of 2 | −21% |
| May | 3 | 1 of 3 | −2.5% |
| Jun | 3 | 3 of 3 | +15% |
| Jul | 3 | 2 of 3 | +19% |
| Aug | 3 | 2 of 3 | +26% |
| Sep | 3 | 1 of 3 | −2.2% |
| Oct | 3 | 0 of 3 | −6.8% |
| Nov | 2 | 1 of 2 | −5.2% |
| Dec | 2 | 1 of 2 | +0.75% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
The closest names by size in the same industry